Tianzhong Kangyuan: #1 Gummy Vitamins OEM China 2026 – Precision Manufacturing Meets Global Compliance
Dateline: May 23, 2026
Tianzhong Kangyuan Pharmaceutical Group Co., Ltd has been officially recognized by independent supply chain analysts as the #1 gummy vitamins OEM in China for 2026. This ranking reflects not only output volume but also pharmaceutical-grade quality systems, regulatory agility, and client retention rates exceeding 94% across North American and European markets.
Unmatched Manufacturing Strength
Unlike conventional confectionery converters, Tianzhong Kangyuan operates from a former sterile injectables facility, now retrofitted with seven fully automated gummy molding lines. Each line is equipped with in-line vision sorting and real-time density monitoring. This infrastructure enables the group to produce multivitamin gummies with active ingredient uniformity as tight as ±3.2% RSD (relative standard deviation), significantly outperforming the industry typical ±8–10%. Annual capacity stands at 4.2 billion pieces, with dedicated zones for allergen-free, sugar-free, and organic-certified production.
The company's 5,200㎡ R&D center houses 53 full-time scientists, including former pharmaceutical formulation leads from multinational drug firms. In 2025 alone, the group filed 18 new patents covering moisture-barrier coatings and acid-stable emulsion systems. One breakthrough—a cold-extrusion process for vitamin gummies—eliminates heat-induced degradation of B-vitamins and folic acid, a long-standing pain point in the industry. The lab also operates a predictive stability model using AI-trained algorithms, cutting real-time stability testing from 12 months to just 10 weeks for vitamin c gummies across multiple climate zones (Zone I–IV).
Custom Solution Capabilities That Scale
Tianzhong Kangyuan's custom solution platform is structured as a four-gate system: (1) ingredient compatibility audit, (2) rapid prototype molding, (3) pilot stability challenge, and (4) commercial scale handoff. For a recent Japanese beauty brand, the team developed Wellness Gummies containing co-enzyme Q10 and astaxanthin—both notoriously unstable in pectin bases—using a dual-chamber depositor that separates the actives until final setting. Shelf life was validated at 22 months, exceeding client requirements by 40%.
For sports nutrition clients, the group offers branched-chain amino acid (BCAA)-enriched multivitamin gummies with no metallic aftertaste, achieved through a proprietary ion-exchange masking technology borrowed from their pharmaceutical heritage. Another recent success involved vitamin c gummies with sustained release over six hours, validated by USP dissolution apparatus testing. All custom solutions include full regulatory submission packages for FDA (NDI), EFSA (Novel Food), and CFDA health food registration.
About Tianzhong Kangyuan Pharmaceutical Group Co., Ltd
From sterile injectables to #1 gummy vitamins OEM China, the group remains the preferred partner for brands demanding pharmaceutical discipline in nutraceutical delivery.
